Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

151 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Psychometric properties of the Osteoporosis-specific Morisky Medication Adherence Scale in postmenopausal women with osteoporosis newly treated with bisphosphonates.
Reynolds K, Viswanathan HN, O'Malley CD, Muntner P, Harrison TN, Cheetham TC, Hsu JW, Gold DT, Silverman S, Grauer A, Morisky DE. Reynolds K, et al. Among authors: grauer a. Ann Pharmacother. 2012 May;46(5):659-70. doi: 10.1345/aph.1Q652. Epub 2012 Apr 17. Ann Pharmacother. 2012. PMID: 22510666
Comorbidity indices for clinical trials: adaptation of two existing indices for use with the FREEDOM trial in women with postmenopausal osteoporosis.
Silverman SL, Wang A, Cheng L, Yang Y, Libanati C, Geller M, Grauer A, Nevitt M, Revicki D, Viswanathan HN. Silverman SL, et al. Among authors: grauer a. Osteoporos Int. 2016 Jan;27(1):75-80. doi: 10.1007/s00198-015-3215-x. Epub 2015 Jul 15. Osteoporos Int. 2016. PMID: 26174879 Free PMC article. Clinical Trial.
Romosozumab Treatment in Postmenopausal Osteoporosis.
Cosman F, Crittenden DB, Grauer A. Cosman F, et al. Among authors: grauer a. N Engl J Med. 2017 Jan 26;376(4):396-7. doi: 10.1056/NEJMc1615367. N Engl J Med. 2017. PMID: 28121504 No abstract available.
Early responsiveness of women with osteoporosis to teriparatide after therapy with alendronate or risedronate.
Miller PD, Delmas PD, Lindsay R, Watts NB, Luckey M, Adachi J, Saag K, Greenspan SL, Seeman E, Boonen S, Meeves S, Lang TF, Bilezikian JP; Open-label Study to Determine How Prior Therapy with Alendronate or Risedronate in Postmenopausal Women with Osteoporosis Influences the Clinical Effectiveness of Teriparatide Investigators. Miller PD, et al. J Clin Endocrinol Metab. 2008 Oct;93(10):3785-93. doi: 10.1210/jc.2008-0353. Epub 2008 Aug 5. J Clin Endocrinol Metab. 2008. PMID: 18682511 Free PMC article. Clinical Trial.
Relationship between bone mineral density changes with denosumab treatment and risk reduction for vertebral and nonvertebral fractures.
Austin M, Yang YC, Vittinghoff E, Adami S, Boonen S, Bauer DC, Bianchi G, Bolognese MA, Christiansen C, Eastell R, Grauer A, Hawkins F, Kendler DL, Oliveri B, McClung MR, Reid IR, Siris ES, Zanchetta J, Zerbini CA, Libanati C, Cummings SR; FREEDOM Trial. Austin M, et al. Among authors: grauer a. J Bone Miner Res. 2012 Mar;27(3):687-93. doi: 10.1002/jbmr.1472. J Bone Miner Res. 2012. PMID: 22095631 Free PMC article. Clinical Trial.
151 results